Exosens shares top the SBF 120, but still down 21% over the quarter
The Bordeaux-based optronics company takes the first place in its index in early afternoon, while the Paris stock market declines. The stock has nevertheless lost a great deal since the summer, and this rebound has not yet changed the medium-term picture.
An isolated gain in a Paris market trending downward
Exosens shares gain 2.23% to €52.65 and hold the first place in the SBF 120, which falls 0.85% at the same time.
The CAC 40 declines 0.88% and the DAX 0.70%: the stock's movement therefore runs against the European markets. It follows the order for image intensifier tubes announced on November 16: 25,000 firm units, and up to 60,000 if the options on 35,000 additional tubes are exercised.
The editorial team has no information explicitly linking today's rise to this announcement, which was already absorbed during Monday's session. In light of the analyst ratings on the stock, the case remains a subject to monitor, but today's price says nothing more.
A rebound that leaves the stock far from its moving averages
Despite this positive session, the stock remains below its 20-day moving average (€54.86, a 4.03% gap), its 50-day moving average (€56.98) and its 200-day moving average (€60.23).
The decline reaches 11.44% over one month and 21.18% over three months, which puts the magnitude of today's rebound into perspective: a 2.23% gain offsets only a small fraction of these losses.
The RSI at 42 remains neutral. The support at €50.90 lies about 3.3% below the current price, while the resistance at €59.65 is well higher, more than 13% above.
The next level to watch is therefore this €50.90 support, while the price seeks to stabilize a downward movement under way for several weeks.